619 related articles for article (PubMed ID: 30837580)
1. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
[TBL] [Abstract][Full Text] [Related]
2. Increased Diagnostic Accuracy of Digital vs. Conventional Clock Drawing Test for Discrimination of Patients in the Early Course of Alzheimer's Disease from Cognitively Healthy Individuals.
Müller S; Preische O; Heymann P; Elbing U; Laske C
Front Aging Neurosci; 2017; 9():101. PubMed ID: 28443019
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.
Müller S; Preische O; Heymann P; Elbing U; Laske C
J Alzheimers Dis; 2017; 55(4):1463-1469. PubMed ID: 27858717
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of a Tablet Computer-Based Cognitive Screening Test for Identification of Amnestic Mild Cognitive Impairment.
Na S; Lee ES; Lee TK
J Korean Med Sci; 2023 May; 38(17):e131. PubMed ID: 37128875
[TBL] [Abstract][Full Text] [Related]
5. The Digital Tree Drawing Test for Screening of Early Dementia: An Explorative Study Comparing Healthy Controls, Patients with Mild Cognitive Impairment, and Patients with Early Dementia of the Alzheimer Type.
Robens S; Heymann P; Gienger R; Hett A; Müller S; Laske C; Loy R; Ostermann T; Elbing U
J Alzheimers Dis; 2019; 68(4):1561-1574. PubMed ID: 30909229
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning Analysis of Digital Clock Drawing Test Performance for Differential Classification of Mild Cognitive Impairment Subtypes Versus Alzheimer's Disease.
Binaco R; Calzaretto N; Epifano J; McGuire S; Umer M; Emrani S; Wasserman V; Libon DJ; Polikar R
J Int Neuropsychol Soc; 2020 Aug; 26(7):690-700. PubMed ID: 32200771
[TBL] [Abstract][Full Text] [Related]
7. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
[TBL] [Abstract][Full Text] [Related]
9. A tablet-based multi-dimensional drawing system can effectively distinguish patients with amnestic MCI from healthy individuals.
Zhang X; Lv L; Shen J; Chen J; Zhang H; Li Y
Sci Rep; 2024 Jan; 14(1):982. PubMed ID: 38200020
[TBL] [Abstract][Full Text] [Related]
10. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
11. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
12. Clock drawing test in screening for Alzheimer's dementia and mild cognitive impairment in clinical practice.
Vyhnálek M; Rubínová E; Marková H; Nikolai T; Laczó J; Andel R; Hort J
Int J Geriatr Psychiatry; 2017 Sep; 32(9):933-939. PubMed ID: 27466038
[TBL] [Abstract][Full Text] [Related]
13. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.
Roalf DR; Moberg PJ; Xie SX; Wolk DA; Moelter ST; Arnold SE
Alzheimers Dement; 2013 Sep; 9(5):529-37. PubMed ID: 23260866
[TBL] [Abstract][Full Text] [Related]
14. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
[TBL] [Abstract][Full Text] [Related]
16. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
17. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
[TBL] [Abstract][Full Text] [Related]
18. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
[TBL] [Abstract][Full Text] [Related]
19. Education-Based Cutoffs for Cognitive Screening of Alzheimer's Disease.
Alenius M; Ngandu T; Koskinen S; Hallikainen I; Hänninen T; Karrasch M; Kivipelto M; Raivio MM; Laakkonen ML; Krüger J; Suhonen NM; Hokkanen L
Dement Geriatr Cogn Disord; 2022; 51(1):42-55. PubMed ID: 35196653
[TBL] [Abstract][Full Text] [Related]
20. CERAD-neuropsychological battery in screening mild Alzheimer's disease.
Sotaniemi M; Pulliainen V; Hokkanen L; Pirttilä T; Hallikainen I; Soininen H; Hänninen T
Acta Neurol Scand; 2012 Jan; 125(1):16-23. PubMed ID: 21198445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
